Dosage	NN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
adjustments	NNS	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
for	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
patients	NNS	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
taking	VBG	acl	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
,	,	punct	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
,	,	punct	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
or	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	nmod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inducers	NNS	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
for	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
greater	JJR	amod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
than	IN	quantmod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
14	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
days	NNS	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O

Patients	NNS	nsubj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Taking	VBG	csubj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
400	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	NN	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
of	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
ABILIFY	NNS	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
MAINTENA	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Strong	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NNP	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
or	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
300	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	IN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NN	nmod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
and	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
200	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	NN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inducers	NNS	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Avoid	VB	aux	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
use	VBP	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Patients	NNPS	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Taking	VBG	xcomp	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
300	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	NN	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
of	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
ABILIFY	NNS	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
MAINTENA	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
Strong	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NNP	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
or	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
200	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	NN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NNP	nmod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
and	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitors	NNS	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
160	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
mg	NN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NNP	nsubj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inducers	NNS	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O

With	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
concomitant	JJ	amod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
use	NN	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
of	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
ABILIFY	NNS	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
MAINTENA	NNP	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
with	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
a	DT	det	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
strong	JJ	amod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP3A4	NN	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitor	NN	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
or	CC	cc	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
CYP2D6	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
inhibitor	NN	conj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
for	IN	prep	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
more	JJR	amod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
than	IN	quantmod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
14	CD	nummod	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
days	NNS	pobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
,	,	punct	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
reduce	VB	ROOT	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
the	DT	det	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
ABILIFY	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
MAINTENA	NNP	compound	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
dosage	NN	dobj	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
.	.	punct	ABILIFY_MAINTENA_ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6	O
